Cargando…
Diabetes Prevalence and Risk Factors in Patients With Chronic Mental Illness on Second-Generation Antipsychotics
The rates of obesity and type 2 diabetes (T2D) are much higher in patients with chronic mental illness compared to the general population(1). Second-generation antipsychotic medications (SGA) are clearly contributory to these adverse metabolic phenotypes(2). Thus, annual monitoring of fasting plasma...
Autores principales: | Sahay, Priya, Shikh, Simran, Akinbowale, Carol, Azim, Salman Meher, Lamberti, J Steven, Olivares, Telva E, Brazill, Kevin P, Miedlich, Susanne U |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090363/ http://dx.doi.org/10.1210/jendso/bvab048.836 |
Ejemplares similares
-
SUN-148 Are Glp Analogues Superior For Diabetes And Weight Control In Patients On Antidepressant Medications?
por: Azim, Salman, et al.
Publicado: (2019) -
MON-167 Hypoglycemia Prevention: A Quality Improvement Project to Reduce Inpatient Hypoglycemia Rate Following Treatment of Hyperkalemia
por: Khan, Nushin, et al.
Publicado: (2019) -
Hyperglycemia Is Associated With Increased Mortality in Critically Ill Patients With COVID-19
por: Bass*, Ilana R, et al.
Publicado: (2021) -
SAT-639 Is the Freestyle Libre Flash Glucose Monitor Accurate in the Critically Ill?
por: Johnson-Rabbett, Brianna, et al.
Publicado: (2020) -
SAT-132 Improvements Seen Among Clinicians Post-CME Related to Second-Line T2D Therapy
por: Larkin, Amy, et al.
Publicado: (2019)